Hospital acquired infections in COVID-19 patients in sub intensive care unit: analysis of two waves of admissions.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
26 10 2022
26 10 2022
Historique:
received:
30
06
2022
accepted:
13
09
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
The pandemic caused by SARS-COV-2 has increased Semi-Intensive Care Unit (SICU) admission, causing an increase in healthcare-associated infection (HAI). Mostly HAI reveals the same risk factors, but fewer studies have analyzed the possibility of multiple coinfections in these patients. The study aimed was to identify patterns of co-presence of different species describing at the same time the association between such patterns and patient demographics and, finally, comparing the patterns between the two cohorts of COVID-19 patients admitted at Policlinico during the first wave and the second one). All the patients admitted to SICUs during two COVID-19 waves, from March to June 2020 months and from October to December 2020, were screened following the local infection control surveillance program; whoever manifested fever has undergone on microbiological culture to detect bacterial species. Statistical analysis was performed to observe the existence of microbiological patterns through DBSCAN method. 246 patients were investigated and 83 patients were considered in our study because they presented infection symptoms with a mean age of 67 years and 33.7% of female patients. During the first and second waves were found respectively 10 and 8 bacterial clusters with no difference regarding the most frequent species. The results show the importance of an analysis which considers the risk factors for the possibility of co- and superinfection (such as age and gender) to structure a good prognostic tool to predict which patients will encounter severe coinfections during hospitalization.
Sections du résumé
BACKGROUND AND AIM
The pandemic caused by SARS-COV-2 has increased Semi-Intensive Care Unit (SICU) admission, causing an increase in healthcare-associated infection (HAI). Mostly HAI reveals the same risk factors, but fewer studies have analyzed the possibility of multiple coinfections in these patients. The study aimed was to identify patterns of co-presence of different species describing at the same time the association between such patterns and patient demographics and, finally, comparing the patterns between the two cohorts of COVID-19 patients admitted at Policlinico during the first wave and the second one).
METHODS
All the patients admitted to SICUs during two COVID-19 waves, from March to June 2020 months and from October to December 2020, were screened following the local infection control surveillance program; whoever manifested fever has undergone on microbiological culture to detect bacterial species. Statistical analysis was performed to observe the existence of microbiological patterns through DBSCAN method.
RESULTS
246 patients were investigated and 83 patients were considered in our study because they presented infection symptoms with a mean age of 67 years and 33.7% of female patients. During the first and second waves were found respectively 10 and 8 bacterial clusters with no difference regarding the most frequent species.
CONCLUSIONS
The results show the importance of an analysis which considers the risk factors for the possibility of co- and superinfection (such as age and gender) to structure a good prognostic tool to predict which patients will encounter severe coinfections during hospitalization.
Identifiants
pubmed: 36300221
doi: 10.23750/abm.v93i5.13402
pmc: PMC9686160
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2022313Références
Acta Biomed. 2020 Apr 20;91(2):31-34
pubmed: 32420921
PLoS One. 2020 Jan 10;15(1):e0227139
pubmed: 31923281
Allergy. 2020 Jul;75(7):1742-1752
pubmed: 32239761
Acta Biomed. 2020 Sep 07;91(3):e2020017
pubmed: 32921713
Anaesth Crit Care Pain Med. 2020 Oct;39(5):553-561
pubmed: 32278670
JAMA. 2020 Apr 28;323(16):1612-1614
pubmed: 32191259
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1380-1388
pubmed: 32275452
Am J Infect Control. 2016 Dec 1;44(12):1600-1605
pubmed: 27324612
Ann Ig. 2017 Mar-Apr;29(2):101-115
pubmed: 28244579
Global Health. 2020 Oct 8;16(1):94
pubmed: 33032616
Intern Emerg Med. 2013 Dec;8(8):717-23
pubmed: 22249916
J Infect. 2020 Jun;80(6):639-645
pubmed: 32240670
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
J Infect Chemother. 2022 Jul;28(7):948-954
pubmed: 35440370
Acta Biomed. 2020 Jul 20;91(9-S):90-91
pubmed: 32701922
Infect Drug Resist. 2018 Nov 15;11:2321-2333
pubmed: 30532565
Nat Rev Microbiol. 2014 Apr;12(4):252-62
pubmed: 24590244
Br J Anaesth. 2020 Sep;125(3):e318-e319
pubmed: 32534737
Travel Med Infect Dis. 2020 Nov - Dec;38:101761
pubmed: 32497768
J Appl Physiol (1985). 2021 Mar 1;130(3):877-891
pubmed: 33444117
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Clin Microbiol Infect. 2021 Jan;27(1):83-88
pubmed: 32745596